01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2012–FY2017. Drag across the bars to change the range.
- $28.83B
1 older move runs past ±150% (largest +289.1%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is Teva Pharmaceutical Industries's current long-term debt?
Teva Pharmaceutical Industries (TEVA) annual long-term debt for 2017 was $28.83B, a 11.36% decline from 2016. Teva Pharmaceutical Industries long-term debt for the quarter ending December 31, 2017 was $28.83B.
What was Teva Pharmaceutical Industries's long-term debt in 2016?
Teva Pharmaceutical Industries annual long-term debt for 2016 was $32.52B, a 289.14% increase from 2015.
What was Teva Pharmaceutical Industries's long-term debt in 2015?
Teva Pharmaceutical Industries annual long-term debt for 2015 was $8.36B, a 2.43% decline from 2014.
What is Teva Pharmaceutical Industries's 5-year long-term debt CAGR?
Teva Pharmaceutical Industries long-term debt grew at a compound annual growth rate (CAGR) of 15.31% from FY2012 to FY2017, going from $14.14B to $28.83B over 5 years.
- Company
- Teva Pharmaceutical Industries
- Ticker
- TEVA
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations